AI Meets Pharma - China’s MindRank Launches Phase 3 Trial for AI-Designed Weight-Loss Drug
AI Meets Pharma: China’s MindRank Launches Phase 3 Trial for AI-Designed Weight-Loss DrugIn a milestone for biotech and artificial intelligence, Hangzhou-based startup MindRank has kicked off Phase 3 clinical trials in China for MDR-001, a weight-loss drug designed with AI...
